Bruno Cazin

5.3k citations

47 papers · 1.8k indexed · h-index 19

Impact in

Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research
Pathology and Forensic Medicine top 1%
- Lymphoma Diagnosis and Treatment

Papers in

Genetics 35
- Chronic Lymphocytic Leukemia Research 35
Pathology and Forensic Medicine 27
- Lymphoma Diagnosis and Treatment 25

Co-authors: M Leporrier B Desablens Brigitte Dreyfus Karim Maloum Guillaume Dighiero Philippe Travade J. Jaubert Jacques‐Louis Binet
Journals: Blood (18 papers)Leukemia (4 papers)British Journal of Haematology (2 papers)Seminars in Oncology (2 papers)Cancer (1 paper)
Partner nations: France Belgium United States

In The Last Decade

Bruno Cazin

45 papers receiving 1.8k citations

Peers

Countries citing papers authored by Bruno Cazin

Since Specialization

Citations

This map shows the geographic impact of Bruno Cazin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruno Cazin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruno Cazin more than expected).

Fields of papers citing papers by Bruno Cazin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruno Cazin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruno Cazin. The network helps show where Bruno Cazin may publish in the future.

Co-authors

The 25 scholars most cited alongside Bruno Cazin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bruno Cazin Line = papers co-authored together Bruno Cazin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Salvage outcomes in patients with first relapse after fludarabine, cyclophosphamide, and rituximab for chronic lymphocytic leukemia: The French intergroup experience American Journal of Hematology ·Luc‐Matthieu Fornecker, Thérèse Aurran‐Schleinitz, Anne‐Sophie Michallet, Bruno Cazin, Romain Guièze, Marie‐Sarah Dilhuydy, Jean‐Marc Zini, Cécile Tomowiak, Stéphane Leprêtre, Florence Cymbalista, Annie Brion, Pierre Feugier, Alain Delmer, Véronique Leblond, Loïc Ysebaert	2015	17
2	First immunochemotherapy outcomes in elderly patients with CLL: A retrospective analysis Journal of Geriatric Oncology ·Anne‐Sophie Michallet, Bruno Cazin, E Bouvet, Lucie Obéric, D Schlaifer, Laurent Mosser, Gilles Salles, Bertrand Coiffier, Laurent Guy, Loïc Ysebaert	2013	11
3	Acadesine for patients with relapsed/refractory chronic lymphocytic leukemia (CLL): a multicenter phase I/II study Cancer Chemotherapy and Pharmacology ·Eric Van Den Neste, Bruno Cazin, Ann Janssens, Eva González‐Barca, María José Terol, Vincent Lévy, Jaime Pérez de Oteyza, Pierre Zachée, Andrew Saunders, Mercè de Frías, Clara Campàs	2012	44
4	Impact of dose intensity on outcome of fludarabine, cyclophosphamide, and rituximab regimen given in the first-line therapy for chronic lymphocytic leukemia Haematologica ·E Bouvet, Cécile Borel, Lucie Obéric, Gisèle Compaci, Bruno Cazin, A.S. Michallet, G. Laurent, Loïc Ysebaert	2012	36
5	Leucémie lymphoïde chronique révélée par des infiltrats cutanés spécifiques en l’absence d’hyperlymphocytose : deux observations Annales de Dermatologie et de Vénéréologie ·M. Vonarx, O. Carpentier, Bruno Cazin, B. Bouchindhomme, Éric Delaporte	2012	2
6	Consolidation Therapy with Subcutaneous Alemtuzumab After Induction Treatment with Oral FC (Fludarabine and Cyclophosphamide) in Previously Untreated Patients Aged 65–70 Years with Advanced Stage Chronic Lymphocytic Leukemia (CLL): Final Results of a Phase II Study From the FCGCLL/WM, Blood ·Alain Delmer, Olivier Tournilhac, Stéphane Leprêtre, Bruno Cazin, Pierre Feugier, Brigitte Dreyfus, Beatrice Mahé, M Leporrier, Anne‐Sophie Michallet, Arnaud Jaccard, Marine Diviné, Vincent Lévy, Florence Cymbalista, Rémi Letestu	2011	1
7	Rituximab–cyclophosphamide–dexamethasone combination in the management of autoimmune cytopenias associated with chronic lymphocytic leukemia Leukemia ·Julien Rossignol, A.S. Michallet, Lucie Obéric, Matthieu Picard, Andrea Canto Garon, Christophe Willekens, Rémy Duléry, Xavier Leleu, Bruno Cazin, Loïc Ysebaert	2010	57
8	IGHV gene mutational status and LPL/ADAM29 gene expression as clinical outcome predictors in CLL patients in remission following treatment with oral fludarabine plus cyclophosphamide Annals of Hematology ·Karim Maloum, Catherine Settegrana, Élise Chapiro, Bruno Cazin, Stéphane Leprêtre, Alain Delmer, M Leporrier, Brigitte Dreyfus, Olivier Tournilhac, Beatrice Mahé, Florence Nguyen‐Khac, Claude Lesty, Frédéric Davi, Hélène Merle‐Béral	2009	23
9	High efficacy with five days schedule of oral fludarabine phosphate and cyclophosphamide in patients with previously untreated chronic lymphocytic leukaemia British Journal of Haematology ·Bruno Cazin, Marine Diviné, Stéphane Leprêtre, Philippe Travade, Olivier Tournilhac, Alain Delmer, J. Jaubert, Pierre Feugier, Brigitte Dreyfus, Beatrice Mahé, B. Grosbois, Frédéric Maloisel, Houchingue Eghbali, Charles Dumontet, Jacques Bénichou, Odile Guibon, Xavier Leleu, M Leporrier, Karim Maloum	2008	13
10	Chronic lymphocytic leukaemia cells are efficiently killed by an anti‐CD20 monoclonal antibody selected for improved engagement of FcγRIIIA/CD16 British Journal of Haematology ·Christophe de Romeuf, Charles‐Antoine Dutertre, Magali Le Garff‐Tavernier, Nathalie Fournier, Christine Gaucher, Arnaud Glacet, Sylvie Jorieux, Nicolas Bihoreau, Christian K. Behrens, R Béliard, Vincent Vieillard, Bruno Cazin, Dominique Bourel, Jean‐François Prost, Jean‐Luc Teillaud, Hélène Merle‐Béral	2008	97
11	Transplantation in Waldenstrom's macroglobulinemia—the French experience Seminars in Oncology ·Olivier Tournilhac, V. Leblond, Reza Tabrizi, Rémy Gressin, Delphine Sénécal, Nöel Milpied, Bruno Cazin, Marine Diviné, Brigitte Dreyfus, J Cahn, B. Pignon, B Desablens, Jean‐Françóis Perrier, Jacques‐Olivier Bay, Philippe Travade	2003	38
12	Campath-1H Treatment of T-Cell Prolymphocytic Leukemia in Patients for Whom at Least One Prior Chemotherapy Regimen Has Failed Journal of Clinical Oncology ·Michael J. Keating, Bruno Cazin, Steven Coutré, Ruemu Birhiray, Tibor Kovacsovics, Wolfgang Langer, Brian Leber, T.S. Maughan, R. Kanti, Geir E. Tjønnfjord, M. Bekradda, M. Itzhaki, Patrice Herait	2002	73
13	Treatment of Acute Lymphoblastic Leukemia in the Elderly: An Evaluation of Interferon Alpha Given as a Single Agent After Complete Remission Leukemia & lymphoma ·André Delannoy, Bruno Cazin, Xavier Thomas, Réda Bouabdallah, JM Boiron, Françoise Huguet, Nicole Straetmans, Hacène Zerazhi, J P Vernant, Hervé Dombret, C Bilhou-Nabéra, C Charrin, Claude Boucheix, Catherine Sebban, Véronique Lhéritier, D Fière	2002	18
14	Multicenter, randomized comparative trial of fludarabine and the combination of cyclophosphamide-doxorubicin-prednisone in 92 patients with Waldenström macroglobulinemia in first relapse or with primary refractory disease Blood ·Véronique Leblond, Vincent Lévy, Frédéric Maloisel, Bruno Cazin, Jean‐Paul Fermand, Jean‐Luc Harousseau, Liliane Réménieras, Raphaël Porcher, Martine Gardembas, Gérald Marit, Éric Deconinck, B Desablens, François Guilhot, G Philippe, Aspasia Stamatoullas, Odile Guibon	2001	71
15	Evaluating treatment strategies in advanced Waldenström macroglobulinemia: use of quality-adjusted survival analysis Leukemia ·Vincent Lévy, Raphaël Porcher, V. Leblond, JP Fermand, Bruno Cazin, F. Maloisel, JL Harousseau, Liliane Réménieras, Odile Guibon, Sylvie Chevret, (unknown)	2001	15
16	Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients Blood ·M Leporrier, Sylvie Chevret, Bruno Cazin, Najda Boudjerra, Pierre Feugier, B Desablens, Marie‐José Rapp, J. Jaubert, Claudie Autrand, Marine Diviné, Brigitte Dreyfus, Karim Maloum, Philippe Travade, Guillaume Dighiero, Jacques‐Louis Binet, Claude Chastang	2001	298
17	Evaluating treatment strategies in chronic lymphocytic leukemia Journal of Clinical Epidemiology ·Vincent Lévy, Raphaël Porcher, Fabrice Delabarre, M Leporrier, Bruno Cazin, Sylvie Chevret	2001	36
18	Chlorambucil in Indolent Chronic Lymphocytic Leukemia New England Journal of Medicine ·Guillaume Dighiero, Karim Maloum, B Desablens, Bruno Cazin, Maurice Navarro, R Leblay, M Leporrier, J. Jaubert, G. Lepeu, Brigitte Dreyfus, Jacques‐Louis Binet, Philippe Travade, François-Louis Turpin, G. Tertian, Agnès Bichoffe	1998	323
19	Age-adapted induction treatment of acute lymphoblastic leukemia in the elderly and assessment of maintenance with interferon combined with chemotherapy. A multicentric prospective study in forty patients Leukemia ·André Delannoy, Catherine Sebban, Pascale Cony‐Makhoul, Bruno Cazin, Catherine Cordonnier, Réda Bouabdallah, J Cahn, François Dreyfus, Alain Sadoun, Vernant Jp, Caroline Gay, A Broustet, Jl. Michaux, D Fière	1997	25
20	Good correlation between RT-PCR analysis and relapse in Philadelphia (Ph1)-positive acute lymphoblastic leukemia (ALL) Leukemia ·Claude Preudhomme, N Henic, Bruno Cazin, JL Laï, MF Bertheas, M Vanrumbeke, François M. Lemoine, J P Jouet, Eric Deconninck, Brigitte Nelken, Alain Cosson, Pierre Fenaux	1997	60

About Bruno Cazin

Bruno Cazin is a scholar working on Genetics, Pathology and Forensic Medicine, Immunology, Hematology and Public Health, Environmental and Occupational Health, having authored 47 papers that have together received 1.8k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (35 papers), Lymphoma Diagnosis and Treatment (25 papers), Immunodeficiency and Autoimmune Disorders (18 papers), Acute Lymphoblastic Leukemia research (10 papers), Chronic Myeloid Leukemia Treatments (4 papers), Viral-associated cancers and disorders (3 papers), Lung Cancer Research Studies (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). The work is most often cited by research in Genetics (1.3k citations), Pathology and Forensic Medicine (1.1k citations), Hematology (434 citations), Immunology (662 citations) and Oncology (336 citations). Bruno Cazin has collaborated with scholars based in France, Belgium and United States. Frequent co-authors include M Leporrier, B Desablens, Brigitte Dreyfus, Karim Maloum, Guillaume Dighiero, Philippe Travade, J. Jaubert, Jacques‐Louis Binet, Sylvie Chevret and Pierre Feugier. Their work appears in journals such as Blood, Leukemia, British Journal of Haematology, Seminars in Oncology and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact